Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Noble Financial 

Eledon Pharmaceuticals Inc. diskutieren

Eledon Pharmaceuticals Inc.

WKN: A2QL00 / Symbol: ELDN / Name: Eledon Pharma / Aktie / Pharmazeutika / Micro Cap /

2,22 €
7,77 %

Einschätzung Buy
Rendite (%) 88,14 %
Kursziel 9,51
Veränderung
Endet am 27.09.24

Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) is now covered by analysts at Noble Financial. They set an "outperform" rating and a $10.00 price target on the stock.
Ratings data for ELDN provided by MarketBeat

Einschätzung Buy
Rendite (%) 76,19 %
Kursziel 12,24
Veränderung
Endet am 24.10.24

Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) had its price target lowered by analysts at HC Wainwright from $25.00 to $13.00. They now have a "buy" rating on the stock.
Ratings data for ELDN provided by MarketBeat

Einschätzung Buy
Rendite (%) 103,67 %
Kursziel 12,18
Veränderung
Endet am 13.11.24

Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.
Ratings data for ELDN provided by MarketBeat

Einschätzung Buy
Rendite (%) 14,59 %
Kursziel 12,00
Veränderung
Endet am 22.03.25

Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $13.00 price target on the stock.
Ratings data for ELDN provided by MarketBeat

Einschätzung Buy
Rendite (%) 6,00 %
Kursziel 14,84
Veränderung
Endet am 07.05.25

Eledon Pharmaceuticals, Inc. (NASDAQ: ELDN) had its price target raised by analysts at HC Wainwright from $13.00 to $16.00. They now have a "buy" rating on the stock.
Ratings data for ELDN provided by MarketBeat